Before the Heat: What's Actually Going On With THCA and CBDA

Whats The Deal With THCA and CBDA?

In the last post we were pretty upfront that hemp tea isn't a way to get a measured dose of anything, because cannabinoids don't dissolve in water the way you'd want them to for that. So you might reasonably ask, if that's true, why are we even writing about THCA and CBDA at all?

Because they're genuinely interesting on their own terms, separate from the tea question entirely. THCA and CBDA are the raw, acidic forms of THC and CBD as they exist in the living plant, before any heat gets involved. And it turns out these raw forms don't just sit there as weaker, inactive versions waiting to become the "real" thing. They behave differently in the body, through different pathways, and that difference is what's actually got researchers curious.

This is the bit where we're going to be careful with our language, because the research is genuinely early stage, mostly done in animals rather than people, and nowhere near the point where anyone can make claims about what it does for you. But early and interesting aren't the same as nothing, and we think it's worth understanding what's actually being looked at.

What decarboxylation actually changes

Every cannabis or hemp plant produces cannabinoids in their acidic form first. THCA, CBDA, and a few others. Heat triggers a process called decarboxylation, where the acidic molecule loses a small part of its structure and converts into the form most people are familiar with, THC or CBD.

What's interesting is that decarboxylation doesn't just need a flame or an oven. It can happen slowly at room temperature too, just through storage over time. So the raw cannabinoid content of any plant material is partly a freshness question. Older material that's been sitting around has often already lost some of its acidic cannabinoid content to this slow conversion, even if it's never been near any heat.

This is particularly relevant for flower, since the surface area of dried bud means it's more exposed to light and air than a pressed or concentrated format, so storage matters even more. That's actually one of the reasons freshness matters across our range generally, not just for terpenes but for the raw cannabinoid profile too.

Why the raw forms got researchers' attention

For a long time, THCA and CBDA were mostly treated as the boring precursor step, the thing that becomes interesting once it turns into THC or CBD. But a few things changed that picture.

THCA, in its raw form, doesn't bind to the CB1 and CB2 receptors the way THC does. Those are the receptors most associated with the effects people typically connect with cannabis. THCA largely sidesteps them. Instead, researchers found it activates something called PPARγ, a receptor involved in regulating metabolism, which led to a run of animal studies looking at things like fat storage and liver inflammation in mice with diet induced metabolic problems.

CBDA does something similarly distinct. Rather than binding cannabinoid receptors directly, it appears to work by inhibiting an enzyme called COX-2, which is heavily involved in the body's inflammatory response. It's also been studied for its interaction with a serotonin receptor, 5-HT1A, in animal models looking at nausea.

So the short version is, these aren't just "THC and CBD but less potent." They're working through genuinely different mechanisms, which is exactly the kind of thing that makes a compound worth a closer look.

What's actually been studied so far

Worth being really clear here, almost all of this is preclinical, meaning animal models or lab studies rather than human clinical trials. That's an important distinction and we're not going to pretend otherwise.

For THCA, research has looked at its effects on metabolic markers in obese mice, liver inflammation and fibrosis in mouse models, and there's been some interest in seizure activity. On that last point specifically, the evidence is genuinely mixed. A couple of small human case studies exist, and they reported conflicting results, some patients saw fewer seizures, others didn't, and a separate review found no benefit at all. It's a good example of why "early research" doesn't mean "promising results", sometimes it just means "this has been looked at and the picture isn't clear yet."

For CBDA, the COX-2 inhibition angle connects it to inflammation research generally, and the 5-HT1A work has mostly been done in the context of nausea in animal models. There's also been work on a more stable lab-modified version of CBDA, looking at mood related behaviour in rats.

There's also some older research suggesting THCA and unheated cannabis extracts have an effect on immune signalling that doesn't go through the usual CB1/CB2 pathways either, which fits the broader pattern of these raw compounds doing their own thing rather than just being weaker copies of THC and CBD.

What we're not going to say

We're not going to tell you that any of this means THCA or CBDA will do anything specific for you. The honest reality is that most of this research is preclinical, the doses and delivery methods used in lab studies don't translate directly to anything you'd encounter in a product, and there are no approved health claims for either compound under UK law. Anyone telling you otherwise is getting ahead of the actual science.

What we think is fair to say is that these are genuinely active compounds with their own distinct biology, that they're not simply inert versions of THC and CBD waiting to happen, and that the research into them is ongoing and worth keeping an eye on as it develops. That's a different statement to "this will help you," and we think the distinction matters.

Why this connects back to what we actually do

This is partly why freshness and proper testing matter to us beyond just hitting a number on a label. The THCA content shown on our COAs reflects the raw acidic cannabinoid as it exists in the product, and that's a moving target if material sits around too long or gets stored badly. Cold, dark, sealed, all the storage advice we've given across other guides isn't just about preserving terpenes for flavour, it's also relevant to the raw cannabinoid profile itself.

If you want to see what that looks like in practice, our guide to reading a COA walks through what the cannabinoid panel actually tells you, including the THCA figure specifically.

Further reading

If you want to go beyond what we've summarised here, these are some of the actual studies and reviews this piece draws on. Worth a read if you want the full picture rather than our summary of it.

Therapeutic potential of acidic cannabinoids: an update, a recent review covering both THCA and CBDA research broadly

Evaluation of the possible anticonvulsant effect of THCA in murine seizure models, including a fair summary of the mixed human case study evidence

What is CBDA and how is it different from CBD, a more accessible overview of the COX-2 and entourage effect angle

Frequently Asked Questions

Does this mean THCA tea has health benefits?

No, and we'd avoid that framing entirely. The research into THCA and CBDA is preclinical, mostly in animal models, and there are no approved health claims for either compound. What we've covered here is genuinely how these compounds are being studied, not a description of what a cup of tea will do.

If THCA doesn't bind CB1 receptors, does that mean it's completely inactive?

Not inactive, just working through a different pathway. CB1 and CB2 are the receptors most associated with the effects people typically connect with THC. THCA appears to interact more with PPARγ, a receptor involved in metabolism, which is a genuinely different mechanism rather than a weaker version of the same one.

Why does storage affect THCA content?

Decarboxylation, the process that converts THCA to THC, can happen slowly at room temperature over time, not just with heat. So material that's been stored for a long time, or stored badly, will generally have a different raw cannabinoid profile to fresher material. This applies to flower especially, given how exposed dried bud is compared to other formats. It's part of why we talk about storage so much across the range.

Is CBDA available in your range?

Our range is built around THCA, across flower and concentrates, hash, live resin, diamonds, sugar, crumble, badder and isolate. CBDA isn't something we currently stock, though if CBD products are what you're after, Originals CBD is worth a look.

Where can I read the actual research rather than your summary?

We've linked the main sources in the further reading section above. We'd genuinely encourage reading them directly rather than taking our word for it, that's kind of the point of being upfront about where this information comes from.